Applied Therapeutics Inc (NASDAQ: APLT) on Friday, plunged -1.70% from the previous trading day, before settling in for the closing price of $0.47. Within the past 52 weeks, APLT’s price has moved between $0.29 and $10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 26.57%. The company achieved an average annual earnings per share of 21.05%. With a float of $116.52 million, this company’s outstanding shares have now reached $141.58 million.
The extent of productivity of a business whose workforce counts for 35 workers is very important to gauge. In terms of profitability, gross margin is 24.15%, operating margin of -41030.19%, and the pretax margin is -16419.25%.
Applied Therapeutics Inc (APLT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 17.70%, while institutional ownership is 74.84%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.56% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 3.00 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 242.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
The latest stats from [Applied Therapeutics Inc, APLT] show that its last 5-days average volume of 1.78 million was inferior to 2.9 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 95.91%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 48.66%, which indicates a significant decrease from 90.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0364 in the past 14 days, which was lower than the 0.0455 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3901, while its 200-day Moving Average is $2.3705. Now, the first resistance to watch is $0.4787. This is followed by the second major resistance level at $0.4955. The third major resistance level sits at $0.5123. If the price goes on to break the first support level at $0.4451, it is likely to go to the next support level at $0.4283. The third support level lies at $0.4115 if the price breaches the second support level.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 65.39 million based on 141,576K outstanding shares. Right now, sales total 460 K and income totals -105,620 K. The company made 0 K in profit during its latest quarter, and 44,010 K in sales during its previous quarter.
